PubMed

Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review.

Freedland ES.

Nutr Metab (Lond). 2004 Nov 5;1(1):12.PMID: 15530168 [PubMed - as supplied by publisher]Related articlesFree article

Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.

Attallah H, Friedlander AL, Hoffman AR.

Growth Horm IGF Res. 2006 Jul;16 Suppl A:S62-7. Epub 2006 Apr 18. Review.PMID: 16624603 [PubMed - indexed for MEDLINE]Related articles

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ.

Circulation. 2007 Jul 3;116(1):39-48. Epub 2007 Jun 18.PMID: 17576866 [PubMed - indexed for MEDLINE]Related articlesFree article

11beta-hydroxysteroid dehydrogenase type 1 and obesity.

Morton NM, Seckl JR.

Front Horm Res. 2008;36:146-64. Review.PMID: 18230901 [PubMed - indexed for MEDLINE]Related articles

Metabolic obesity: the paradox between visceral and subcutaneous fat.

Hamdy O, Porramatikul S, Al-Ozairi E.

Curr Diabetes Rev. 2006 Nov;2(4):367-73. Review.PMID: 18220642 [PubMed - indexed for MEDLINE]Related articles

Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity.

Park HS, Lee K.

Diabet Med. 2005 Mar;22(3):266-72.PMID: 15717873 [PubMed - indexed for MEDLINE]Related articles

Metabolic and body composition factors in subgroups of obesity: what do we know?

Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET.

J Clin Endocrinol Metab. 2004 Jun;89(6):2569-75. Review.PMID: 15181025 [PubMed - indexed for MEDLINE]Related articlesFree article

11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.

Paulsen SK, Pedersen SB, Fisker S, Richelsen B.

Obesity (Silver Spring). 2007 Aug;15(8):1954-60.PMID: 17712112 [PubMed - indexed for MEDLINE]Related articles

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. Epub 2008 Mar 20. Review. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):e151. PMID: 18356555 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular disease under the influence of excess visceral fat.

Després JP.

Crit Pathw Cardiol. 2007 Jun;6(2):51-9. Review.PMID: 17667865 [PubMed - indexed for MEDLINE]Related articles

Subcutaneous and visceral adipose tissue: structural and functional differences.

Ibrahim MM.

Obes Rev. 2009 Jul 28. [Epub ahead of print]PMID: 19656312 [PubMed - as supplied by publisher]Related articles

Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal women.

Langendonk JG, Kok P, Frölich M, Pijl H, Meinders AE.

Eur J Intern Med. 2006 Nov;17(7):465-9.PMID: 17098588 [PubMed - in process]Related articles

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women.

Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB.

Arch Intern Med. 2005 Apr 11;165(7):777-83.PMID: 15824297 [PubMed - indexed for MEDLINE]Related articlesFree article

11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.

Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A, Grino M.

Obesity (Silver Spring). 2006 May;14(5):794-8.PMID: 16855188 [PubMed - indexed for MEDLINE]Related articles

Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.

Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM, Andrew R, Seckl JR, Walker BR.

Clin Endocrinol (Oxf). 2006 Jul;65(1):81-7.PMID: 16817824 [PubMed - indexed for MEDLINE]Related articles

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.PMID: 17681171 [PubMed - indexed for MEDLINE]Related articles

[Relation between insulin resistance and amount of visceral adipose tissue]

Bajzová M, Kováciková M, Vítková M, Polák J, Klimcáková E, Srp A, Vedral T, Mikulásek L, Srámková SP, Stich V, Hejnová J.

Cas Lek Cesk. 2008;147(7):376-80. Czech. PMID: 18678096 [PubMed - indexed for MEDLINE]Related articles

Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.

Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y, Asayama K, Shirahata A.

Obesity (Silver Spring). 2008 Feb;16(2):384-8.PMID: 18239648 [PubMed - indexed for MEDLINE]Related articles

High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.

Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R.

Diabetes. 2008 Feb;57(2):367-71. Epub 2007 Oct 31.PMID: 17977954 [PubMed - indexed for MEDLINE]Related articlesFree article

Is visceral obesity the cause of the metabolic syndrome?

Després JP.

Ann Med. 2006;38(1):52-63. Review.PMID: 16448989 [PubMed - indexed for MEDLINE]Related articles